On related topic:

What about getting a K23 AFTER some time spent in a slot on a K12?

Is the rule for total support institute dependent?

thanks

Charlie

> Hi Jennifer,
> Here is the language that you were looking for (from the NIH Grants Policy
> Statement, Part II: Terms and Conditions of NIH Grant Awards);
> "No fellow may receive more than 5 years of aggregate Kirschstein-NRSA
> support at the predoctoral level and 3 years of aggregate Kirschstein-NRSA
> support at the postdoctoral level, including any combination of
> Kirschstein-NRSA support from institutional research training grants and
> individual fellowships."
> Jadwiga Kawka
> Yale School of Public Health
> 135 College St.
> New Haven,  CT 06520
> Tel:  (203) 785-2821
> Fax: (203 785-7296
> e-mail: xxxxxx@yale.edu<mailto:xxxxxx@yale.edu>
>
> ________________________________
> From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf
> Of Jennifer Chappelle
> Sent: Tuesday, September 15, 2009 1:35 PM
> To: xxxxxx@hrinet.org
> Subject: [RESADM-L] Question about NRSA support
>
> Good afternoon everyone,
>
> We have a fairly simple question for the T32 gurus out there:
>
> We know there are limits on years a trainee can be supported as a pre-doc,
> as well as limits on years supported as a post-doc.  Does anyone know if
> there are combination limits?  Specifically, if someone has been supported
> for 4 years as a pre-doc, can they be supported for one or more years as a
> post-doc?  If they have been supported as a pre-doc for 5 years, can they
> be supported at all as a post-doc?  If there are limits, can you point me
> to the language?
>
> Thanks very much,
>
> Jennifer
>
>
>
>
>
>
>
> The information in this e-mail is intended only for the person to whom it
> is
>
> addressed. If you believe this e-mail was sent to you in error and the
> e-mail
>
> contains patient information, please contact the Partners Compliance
> HelpLine at
>
> http://www.partners.org/complianceline . If the e-mail was sent to you in
> error
>
> but does not contain patient information, please contact the sender and
> properly
>
> dispose of the e-mail.
>
> ======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available via
> our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>
>
> ======================================================================
>  Instructions on how to use the RESADM-L Mailing List, including
>  subscription information and a web-searchable archive, are available
>  via our web site at http://www.hrinet.org (click on "Listserv Lists")
> ======================================================================
>

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================